HANNAH WYATT: Open Payments
NPI 1619480738 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 14 payments from 8 companies in 2025. Trend: 2023 $41 · 2024 $630 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Novo Nordisk Inc | 3 | $51 |
| Astellas Pharma US Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: UBRELVY, Xtandi, QULIPTA, AIRSUPRA, KRYSTEXXA, Wegovy, Kerendia, SHINGRIX.
Industry payments across NC — which companies pay providers there.
